Evaluative Clinical Sciences

Education:

• B.Sc., 1995, human biology, University of Toronto, Canada
• MD, 1999, U of T, Canada
• M.Sc., 2007, health administration (clinical epidemiology), U of T, Canada
• M.Sc., 2010, biostatistics, U of T, Canada
• PhD, 2017, biostatistics, U of T, Canada

Appointments and Affiliations:

• Associate scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute
• Professor, department of medicine, U of T
• Staff medical oncologist, Odette Cancer Centre, Sunnybrook Health Sciences Centre
• Co-director, Canadian Centre for Applied Research in Cancer Control 
• Clinical lead, provincial drug reimbursement programs, Cancer Care Ontario

Research Foci:

• Medical oncology
• Head & neck malignancies
• Clinical epidemiology
• Health economics
• Cost-effectiveness analysis
• GI malignancies
• Decision analysis
• Biostatistics
  

Selected Publications:

See current publications list at PubMed

1. Chan KKW, Shah K, Lien K, Coyle D, Lam H, Ko Y. A Bayesian meta-analysis of multiple treatment comparisons of systemic regimens for advanced pancreatic cancer. PLoS One. 2014 Oct 6;9(10):e108749.
2. Chan KK, Willan AR, Gupta M, Pullenayegum E. Underestimation of uncertainties in health utilities dervied from mapping algorithms involving health-related quality-of-life measures: statistical explanations and potential remedies. Med Decis Making. 2014 Oct;34(7):863–72.
3. Chan KK, Siu E, Cheung MC, Mozessohn L. Publication patterns of cancer cost-effectiveness studies presented at major conferences. Curr Oncol. 2013 Dec;20(6):319–25.
4. Chan KK, Wong B, Siu LL, Straus SE, Chang J, Berry SR. Less than ideal: how oncologists practice with limited drug access. J of Oncol Pract. 2012 May;8(3):190–5.
5. Chan KK, Siu E, Krahn M, Imrie K, Alibhai S. Cost-utility analysis of primary prophylaxis versus secondary prophylaxis with granulocyte colony-stimulating factor in elderly patients with diffuse aggressive lymphoma receiving curative-intent chemotherapy. J of Clin Oncol. 2012 Apr 1;30(10):1064–71.

Related News and Stories:

• Research into cancer technologies and services recognized with funding: Six Sunnybrook Research Institute scientists working in prevention, screening and care receive support from provincial network (June 4, 2019)